170 related articles for article (PubMed ID: 19477652)
21. A novel FtsZ-like protein is involved in replication of the anthrax toxin-encoding pXO1 plasmid in Bacillus anthracis.
Tinsley E; Khan SA
J Bacteriol; 2006 Apr; 188(8):2829-35. PubMed ID: 16585744
[TBL] [Abstract][Full Text] [Related]
22. Viral hijacking of a replicative helicase loader and its implications for helicase loading control and phage replication.
Hood IV; Berger JM
Elife; 2016 May; 5():. PubMed ID: 27244442
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial Small Molecules That Potently Inhibit Staphylococcus aureus Lipoteichoic Acid Biosynthesis.
Naclerio GA; Karanja CW; Opoku-Temeng C; Sintim HO
ChemMedChem; 2019 May; 14(10):1000-1004. PubMed ID: 30939229
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
Joska TM; Anderson AC
Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.
Nammalwar B; Bourne CR; Bunce RA; Wakeham N; Bourne PC; Ramnarayan K; Mylvaganam S; Berlin KD; Barrow EW; Barrow WW
ChemMedChem; 2012 Nov; 7(11):1974-82. PubMed ID: 22930550
[TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of the PcrA helicase of Bacillus anthracis.
Naqvi A; Tinsley E; Khan SA
J Bacteriol; 2003 Nov; 185(22):6633-9. PubMed ID: 14594837
[TBL] [Abstract][Full Text] [Related]
27. Characterization and in vitro inhibition studies of Bacillus anthracis FtsZ: a potential antibacterial target.
Park HC; Gedi V; Cho JH; Hyun JW; Lee KJ; Kang J; So B; Yoon MY
Appl Biochem Biotechnol; 2014 Mar; 172(6):3263-70. PubMed ID: 24510482
[TBL] [Abstract][Full Text] [Related]
28. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
29. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
[TBL] [Abstract][Full Text] [Related]
31. Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
Panchal RG; Ulrich RL; Lane D; Butler MM; Houseweart C; Opperman T; Williams JD; Peet NP; Moir DT; Nguyen T; Gussio R; Bowlin T; Bavari S
Antimicrob Agents Chemother; 2009 Oct; 53(10):4283-91. PubMed ID: 19635954
[TBL] [Abstract][Full Text] [Related]
32. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
[TBL] [Abstract][Full Text] [Related]
33. Polysaccharide deacetylases serve as new targets for the design of inhibitors against Bacillus anthracis and Bacillus cereus.
Balomenou S; Koutsioulis D; Tomatsidou A; Tzanodaskalaki M; Petratos K; Bouriotis V
Bioorg Med Chem; 2018 Jul; 26(13):3845-3851. PubMed ID: 29983281
[TBL] [Abstract][Full Text] [Related]
34. Efficient growth inhibition of Bacillus anthracis by knocking out the ribonucleotide reductase tyrosyl radical.
Torrents E; Sahlin M; Biglino D; Gräslund A; Sjöberg BM
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):17946-51. PubMed ID: 16322104
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
36. Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa.
Gerits E; Blommaert E; Lippell A; O'Neill AJ; Weytjens B; De Maeyer D; Fierro AC; Marchal K; Marchand A; Chaltin P; Spincemaille P; De Brucker K; Thevissen K; Cammue BP; Swings T; Liebens V; Fauvart M; Verstraeten N; Michiels J
PLoS One; 2016; 11(5):e0155139. PubMed ID: 27167126
[TBL] [Abstract][Full Text] [Related]
37. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T
Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686
[TBL] [Abstract][Full Text] [Related]
38. Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
Turos E; Revell KD; Ramaraju P; Gergeres DA; Greenhalgh K; Young A; Sathyanarayan N; Dickey S; Lim D; Alhamadsheh MM; Reynolds K
Bioorg Med Chem; 2008 Jul; 16(13):6501-8. PubMed ID: 18524602
[TBL] [Abstract][Full Text] [Related]
39. Menaquinone analogs inhibit growth of bacterial pathogens.
Schlievert PM; Merriman JA; Salgado-Pabón W; Mueller EA; Spaulding AR; Vu BG; Chuang-Smith ON; Kohler PL; Kirby JR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5432-7. PubMed ID: 23959313
[TBL] [Abstract][Full Text] [Related]
40. Structure-Activity Relationship Studies of Small Molecule Modulators of the Staphylococcal Accessory Gene Regulator.
Horswill AR; Gordon CP
J Med Chem; 2020 Mar; 63(6):2705-2730. PubMed ID: 31658413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
